Skip to search formSkip to main contentSkip to account menu

Evaluable Disease

Known as: Evaluable 
Disease that cannot be measured directly by the size of the tumor but can be evaluated by other methods specific to a particular clinical trial.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1996
Review
1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study.
Highly Cited
1996
Highly Cited
1996
The Effects of Recombinant Human Erythropoietin on Perioperative Transfusion Requirements in Patients Having a Major Orthopaedic Operation*
Two hundred patients who were scheduled for a major elective orthopaedic operation were enrolled in a prospective study and were… 
Highly Cited
1995
Highly Cited
1995
UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response
Highly Cited
1995
Highly Cited
1995
A prospective multicenter assessment of the Edmonton staging system for cancer pain.
Review
1994
Review
1994
Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.
Paclitaxel is a new anticancer agent with a novel mechanism of action. It promotes polymerisation of tubulin dimers to form… 
Highly Cited
1992
Highly Cited
1992
A chronopharmacologic phase II clinical trial with 5‐fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic…
A significant increase in the dose intensity of chemotherapy with fluoropyrimidines and platinum complexes has resulted from… 
Highly Cited
1991
Highly Cited
1991
Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients.
One hundred and twenty-six patients were treated for 137 episodes of fungal infection with liposomal amphotericin B (AmBisome) at… 
Highly Cited
1991
Highly Cited
1991
Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
Compared with conventional transfusion regimes a strong reduction in HLA alloimmunization and refractoriness to platelet… 
Highly Cited
1988
Highly Cited
1988
Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration.
HLA immunization is a common complication of transfusion therapy in 30% to 60% of oncohematologic patients. Evidence shows that… 
Review
1987
Review
1987
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.
The development of a new multidrug chemotherapy regimen for primary brain tumors was based upon the cellular heterogeneity within… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)